Thomas W Flaig (Thomas Flaig)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Prostate Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

JCO oncology practice

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice 20 (3) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice 20 (3) (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Seth P Lerner, David J McConkey, Catherine M Tangen, Joshua J Meeks, Thomas W Flaig, Xing Hua, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Woonyoung Choi, Rick Bangs, Daniel L Gustafson, Melissa Plets, Ian M Thompson
Association of Molecular Subtypes with Pathologic Response, PFS and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel P Petrylak, Carolyn Sasse, Blanca Homet Moreno, Yao Yu, Anne-Sophie Carret, Jonathan E Rosenberg
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Corbin J Eule, Thomas W Flaig, Katy Wong, Ryon P Graf, Elaine T Lam
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations. Prostate cancer and prostatic diseases (2022)
Samuel R Denmeade, Hao Wang, Archana M Agarwal, David C Smith, Michael Thomas Schweizer, Mark N Stein, Vasileios Assikis, Przemyslaw W Twardowski, Thomas W Flaig, Russell Z Szmulewitz, Jeffrey M Holzbeierlein, Ralph J Hauke, Guru P Sonpavde, Jorge A Garcia, Arif Hussain, A Oliver Sartor, Shifeng S Mao, Harry Cao, Wei Fu, Ting Wang, Rehab Abdallah, Su Jin Lim, Vanessa Cilento, Channing J Paller, Michael A Carducci, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, Pamela J Atherton, Amir Mortazavi, Christopher J Sweeney, Walter M Stadler, Benjamin A Teply, Joel Picus, Scott T Tagawa, Sreedhar Katragadda, Daniel Vaena, Jamal Misleh, Christopher J Hoimes, Elizabeth R Plimack, Thomas W Flaig, Robert Dreicer, Dean F Bajorin, Olwen Hahn, Eric J Small, Michael J Morris
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)